Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Softheia
Softheia
Softheia
Softheia
Softheia
Softheia
Softheia
Softheia
Softheia
Softheia
Softheia
Softheia
Softheia
Softheia
2021

Share:

Softheia

PET device operating system

This product is an operating system for positron emission tomography (PET) equipment. The traditional PET operating system usually requires professionals to operate, while our product uses an intelligent and automated processes which can greatly simplify user operations and improve the reliability of clinical diagnosis. This product has significantly improved the ease of use of medical equipment, having a positive benefit on human health.

Client / Manufacturer

RaySolution Digital Medical Imaging Co., Ltd.

Ezhou, CN
Design
Wuhan AOSI Industry Design Co., Ltd.

Wuhan AOSI Industry Design Co., Ltd.

Wuhan, CN
Date of Launch
2020
Development Time
13 - 24 months
Target Regions
Asia
Target Groups
Other target groups: Nuclear Medicine Department,Cancer patients

RELATED PROJECTS